MeSH tree: D23.050.705.552.450
HLA compatibility is considered the key criterion for selecting donors for allo-HSCT. DKMS study data presented at the DGHO Annual Meeting 2025 in Cologne indicate the biological age of donors has a greater influence on transplant ...
Nov 19, 2025
0
0
Researchers at the University of Pittsburgh have identified a new way of predicting whether a kidney donor and recipient are a good match for transplantation.
Jul 16, 2025
0
51
In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes, "killer cells" able ...
Jun 30, 2025
0
23
Type 1 diabetes (T1D) is an autoimmune condition where the immune system destroys insulin-producing β-cells in the pancreas. Yet, not all patients lose insulin function at the same pace. Understanding this variation is especially ...
Jun 16, 2025
0
0
One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules only expressed by cancer ...
Apr 2, 2025
0
0
Abdominal pain, diarrhea, and debilitating fatigue define the daily lives of millions of people worldwide who suffer from chronic bowel disease. Most of these individuals are diagnosed in their youth, and the disease's progression ...
Oct 17, 2024
0
9
What are the characteristics of a cancer cell that are recognized by the immune system? Knowledge of the potential target structures for the immune cells is a basic prerequisite for the development of personalized cancer ...
Aug 22, 2024
0
20
Using genetic engineering techniques, investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center, the Lustgarten Laboratory and Bloomberg~Kimmel Institute for Cancer Immunotherapy have designed a novel ...
Jul 10, 2024
0
45
Women who have close family members with endocrine diseases--including type 2 diabetes, thyroid diseases and polycystic ovary syndrome (PCOS)--are at higher risk of pregnancy loss, a new study has found.
Jul 9, 2024
0
0
A recent study led by researchers at Tampere University investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease. Previous tissue studies have shown that the ZED1227 transglutaminase ...
Jun 24, 2024
0
52
